Rx PHARMASIST.CA
The Pharmasist newsletter

Stay current in
Canadian pharmacy.

Pharmacy news, practice updates and fresh perspectives—delivered to your inbox.

Keep your practice informed

  • Canadian pharmacy news

    Follow the developments shaping the profession.

  • Prescriber updates

    Stay informed about newly licensed Ontario physicians.

  • What's new on Pharmasist

    Explore new resources, tools and learning opportunities.

Free newsletter

A useful addition to your inbox.

We'll send a confirmation link first. Privacy policy

All news Pharmasist News & insight

Bausch confirms end of two Retin-A products in Canada; remaining stock expected until March

Retin-A 0.05% cream and 0.025% gel are being discontinued for business reasons, Bausch told CTV News. Pharmacists warn alternatives may cost more.

1 min read1 source
Share LinkedIn X Facebook Email
Illustrative photo accompanying this news article
A pharmacy in Tilbury, Ontario; illustrative file photo. Photo: Chris Woodrich / Wikimedia Commons, CC BY-SA 4.0. Image source
In this article & details

Article details

Published
Nov 19, 2026
Reading time
1 min read
Categories
Drug Access, Drug Shortages
Jurisdiction
National
Sources cited
1
All news

Bausch Health has confirmed that it is ending Canadian sales of Retin-A tretinoin cream 0.05% and gel 0.025%, with existing inventory expected to last until approximately March or until supplies run out.

The company told CTV News by email on November 17 that the decision was made for business reasons, unrelated to safety, effectiveness or product quality.

Other tretinoin treatments remain available

In CTV’s November 18 report, University of Toronto pharmacy professor Mina Tadrous said other tretinoin formulations and related medicines remain available and urged patients not to stockpile.

Toronto pharmacist Alexandre Mihaila said changing treatments can involve new adverse effects and higher costs. Dalhousie pharmacy instructor Sarah Larose noted that other medicines in the retinoid class may be options, with availability and drug-plan coverage affecting the choice.

CTV cited a Beyond Health listing of more than $100 for 50 grams of Retin-A Micro, compared with roughly $40 for 30-gram tubes of the discontinued products. Those are different package sizes and formulations, rather than a direct price comparison.

The discontinuation affects the two specified Retin-A products; it does not mean all tretinoin treatments are disappearing from Canada.

References

  1. Popular prescription acne medication discontinued in Canada — CTV News, November 18, 2026; manufacturer confirmation November 17

Discussion

0 comments

Join the discussion. Anyone can read the comments. To comment, log in or create a free individual account.

No comments yet.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.